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Risk factors for hip fracture among patients with end-stage end-stage renal disease (ESRD). ESRD patients, how-
renal disease. ever, are 4.4-fold more likely to sustain a hip fracture
Background. Although bone disease is well described among than the general population [2]. The relative risk (RR)end-stage renal disease (ESRD) patients, little attention has
of hip fracture among ESRD patients varies by age andbeen paid to the occurrence of fracture. We sought to identify
gender and ranges from a 99-fold higher risk among menfactors that are associated with hip fracture among ESRD
patients. younger than 45 years to a 1.7-fold increased risk among
Methods. Data from patients who participated in the United women older than 85 years. Risk factors for hip fracture
States Renal Data System Dialysis Morbidity and Mortality in the general population have been well described andStudy Wave 1 were used for this study. Hip fractures occurring
include bone loss, increasing age, Caucasian race, smok-among these patients between 1993 and 1996 were identified
ing, female gender, and lower body weight [3–7]. Severalfrom Medicare claims data available from the United States
Renal Data System. Cox proportional hazards models were investigators have demonstrated low bone mineral den-
used to estimate the risk of hip fracture associated with demo- sity among ESRD patients [8–11] and have identified renal
graphic and medical variables.
osteodystrophy, ethnicity, age, transplantation, and amen-Results. Of the 4952 patients included in this analysis, 103
orrhea as factors contributing to bone loss. Low bonesustained a hip fracture. In the multivariate analysis, age (per
increasing decade, RR 5 1.40, 95% CI 1.20, 1.64), female mineral density has been associated with an increased
gender (RR 5 2.26, 95% CI 1.48, 3.44), race (blacks compared risk for vertebral fracture among male hemodialysis pa-
with whites, RR 5 0.58, 95% CI 0.37, 0.91), body mass index tients [12]. However, there are no studies identifying
(per 1 unit increase, RR 0.89, 95% CI 0.86, 0.93), and the
risk factors for hip fracture among ESRD patients. Wepresence of peripheral vascular disease (RR 1.94, 95% CI 1.29,
conducted a population-based cohort study to identify2.92) were independently associated with hip fracture. Serum
intact parathyroid hormone (iPTH), aluminum, diabetes, and factors associated with hip fracture among patients with
bicarbonate levels did not appreciably influence the risk of hip ESRD.
fracture.
Conclusions. Demographic and other characteristics that
predict risk of hip fracture in the population at large also do METHODS
so in ESRD patients. However, we could identify no character-
Subjectsistics of ESRD or its treatment that were independently related
to hip fracture incidence. The United States Renal Data System (USRDS) col-
lects demographic and clinical data on every patient in
the United States with ESRD who has survived more
Hip fractures are an important cause of morbidity and than 90 days on dialysis and who qualifies for Medicare.
mortality [1]. Like the general population, the incidence Data from the USRDS Dialysis Morbidity and Mortality
of hip fracture increases with age among patients with Study Wave 1 (DMMS-1) were used for our analysis.
Details of the study design are described elsewhere [13].
Briefly, the USRDS DMMS-1 was a historical prospec-Key words: bone disease, dialysis, epidemiology, renal osteodystrophy,
USRDS Study Wave 1. tive study in which all hemodialysis patients who began
dialysis in December 1993 and a random sample of pa-Received for publication March 22, 2000
tients who had started dialysis prior to December 1993and in revised form June 1, 2000
Accepted for publication June 5, 2000 and were still were alive on December 31, 1993, were
included in the study. Patients were excluded fromÓ 2000 by the International Society of Nephrology
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DMMS-1 if they were less than 15 years of age or were were calculated using the normal approximation to the
Poisson distribution [15].receiving chronic ambulatory peritoneal dialysis or home
hemodialysis at the start of the study. Data for DMMS-1 Cox proportional regression models were used to esti-
mate the risk of hip fracture, modeled for censored fail-were collected by dialysis facility personnel. A question-
naire was completed for each patient, which included ure times. In this model, the hazard, or the instantaneous
probability of fracture, was modeled as a function of thedemographic and medical data. Data were collected on
5591 of the 6300 patients selected for the study, and of predictor covariates. Potential predictor covariates were
identified a priori as biologically plausible risk factorsthese, 38% had begun dialysis in December 1993.
for fracture. Variables were included in the multivariate
Ascertainment of risk factors model either as independent risk factors of fracture after
adjustment for other covariates or in an attempt to con-Covariates that we identified a priori as potential risk
factors for hip fracture included age at study start, gen- trol for confounding. Covariates were deemed confound-
ers if they were found to be associated with both theder, race (black, white, other), coronary artery disease
(CAD), cerebrovascular disease (CVD), peripheral vas- occurrence of fracture as well as a predictor of interest.
The RR or hazard ratio was then estimated for eachcular disease (PVD), cigarette smoking status (never,
former, current), ability to ambulate independently, abil- covariate as the proportionate change in the instanta-
neous probability of fracture for two individuals differingity to transfer independently, body mass index (BMI),
serum parathyroid hormone (PTH), albumin, aluminum, only by a single unit of that covariate. Patients were
censored at death or loss to follow-up. Patients werebicarbonate, calcium, phosphate, and hematocrit. These
variables were abstracted from the DMMS-1 database considered lost to follow-up if no Medicare payments
were made for a period of one year. To account forfor the purposes of our analysis. Laboratory values were
single values measured during December 1993, the changes in ESRD treatment modality between the start
and end of our analysis, treatment modality (hemodialy-month of study start. Data on modality (hemodialysis,
peritoneal dialysis, transplant, dialysis after transplant) sis, peritoneal dialysis, and transplant) was modeled as
were abstracted from the Treatment History File, which a time-dependent covariate. This allowed subjects to
records the sequence of modalities for each patient. The change risk groups as modality changed, more accurately
dates of treatment by each modality for every patient reflecting the contribution of each modality to the risk
were abstracted for all patients. of fracture. Asymptotic normality of the estimated re-
gression coefficients was assumed, permitting the pro-
Ascertainment of hip fracture duction of confidence intervals and P values via the Wald
The occurrence of the first hip fracture among patients test. Results are reported as RRs with 95% CI and two-
in DMMS-1 was determined by identifying International tailed P values. Statistical analysis was performed using
Classification of Diseases, 9th Revision (ICD-9) codes S-Plus 4.5 statistical software (Mathsoft Inc., Seattle,
between December 1993 and December 1997 indicating WA, USA).
cervical, intertrochanteric, or subtrochanteric hip frac-
tures from a separate hospitalization file maintained by
RESULTSthe USRDS. ICD-9 codes are derived from Health Care
Of the 5591 patients included in DMMS Wave-1, 4952Financing Administration Standard Analytical Files,
were included in our analysis. Of the 639 patients excluded,which contain data on inpatient hospital stays and are
357 were missing the identification number required toavailable through 1997. Hip fracture data were linked to
link demographic and medical data to hip fracture dataDMMS-1 using the USRDS-assigned unique identifier.
and 282 did not have a record in the patient or treatment
Statistical analysis file. Patients in the study population had a mean age that
was significantly lower than patients who were excludedThe expected number of hip fractures was calculated
(P , 0.01). Characteristics of the study population areby multiplying the number of person years at risk by the
described in Table 1. The mean follow-up time was 2.86corresponding age specific hip fracture incidence rate
years (median 3.16 years), with a range of 4.67 yearsfrom a reference population, Olmstead County, MN,
(minimum of 1 week to a maximum of 4.67 years).USA [14]. Standardized incidence ratios (SIRs) were
A total of 103 hip fractures was identified. The SIRscomputed as the ratio of the number of observed hip
for hip fracture among Caucasian study patients werefractures and the number of expected hip fractures. SIRs
3.17 (2.04 to 4.93) for males and 4.11 (2.96 to 5.73) forwere internally standardized for age and reported for
females. For the entire study population, the SIRs formen and women. Because the reference population is
hip fracture were 3.12 (2.13 to 4.59) for males and 3.35primarily Caucasian and hip fracture incidence is known
(2.59 to 4.40) for females.to vary by race, SIRs were also estimated after restricting
the study population to Caucasians. Confidence intervals The results of the bivariate analysis are presented in
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Table 1. Characteristics of the study sample and excluded populationa The final model is shown in Table 3. Factors that were
independently associated with an increased risk of hipStudy
population Excluded fracture included increasing age, female gender, Cauca-
(N 5 4952) (N 5 639) sian race, lower BMI, and the presence of PVD. Individu-
Characteristic Mean (SD) or frequency (%) als aged 66 to 80 years and .80 years had a twofold
Age years 59.7 (15.6) 67.3 (14.8) and sixfold increased risk for hip fracture, respectively,
Female gender 48.3 61.3 compared with those less than 50 years (adjusted RR 5
Race
2.25, 95% CI 1.24 to 4.10, P , 0.008; adjusted RR 5Caucasian 52.1 44.6
Black 39.8 41.4 5.98, 95% CI 2.98 to 11.98, P , 0.001). Blacks had a
Other 8.1 14.0 42% lower risk of fracture compared with Caucasian
BMI kg/m2 24.8 (5.91) 24.4 (7.68)
ethnicity (adjusted RR 5 0.58, 95% CI 0.37 to 0.91, P ,Peripheral vascular disease 27.2 24.4
CHD/CAD 40.8 37.5 0.02). Women had a twofold higher risk of hip fracture
Cerebrovascular accident 15.4 12.7 compared with men (adjusted RR 5 2.26, 95% CI 1.48
Diabetes 37.0 37.9
to 3.44, P , 0.001). The presence of PVD was associatedTime on dialysis (as of 12/31/93) 2.83 (3.44) 4.15 (4.78)
Smoking with a twofold increased risk of hip fracture (adjusted
Never 54.7 58.7 RR 5 1.94, 95% CI 1.29 to 2.92, P 5 0.002). A BMI of
Former 29.0 24.7
less than 23 was associated with a twofold increase inCurrent 16.3 16.7
Independent transferring 87.3 82.7 the risk for hip fracture (adjusted RR 5 2.51, 95% CI
Independent ambulating 85.9 82.7 1.65 to 3.82, P , 0.001).
PTH pg/mL 323.8 (552.0) 334.6 (554.3)
Calcium mg/dL 9.14 (1.12) 9.03 (1.12)
Albumin g/dL 3.72 (0.48) 3.71 (0.54)
DISCUSSIONAluminum lg/L 19.1 (28.7) 19.1 (22.8)
Phosphorous mg/dL 5.93 (2.02) 5.93 (2.04) In this population-based study of patients with ESRD,
Bicarbonate mEq/L 19.9 (4.14) 20.0 (6.11)
older age, female gender, Caucasian ethnicity, lowerHematocrit % 30.2 (4.62) 29.7 (4.99)
BMI, and PVD were independent predictors of hip frac-Abbreviations are: BMI, body mass index; CHD/CAD, chronic heart disease/
coronary artery disease; PTH, parathyroid hormone. ture. Characteristics of ESRD or its treatment including
a As of December 31, 1993 serum iPTH, aluminum, calcium, phosphate, and bicar-
bonate levels were not independent predictors of hip
fracture.
Our data are consistent with our previous report dem-Table 2. Increasing age, female gender, Caucasian race,
onstrating a fourfold increased risk for hip fracturelower BMI, PVD, CVD, the inability to transfer and
among ESRD patients [2]. In the current study, the riskambulate independently, and lower serum albumin were
of hip fracture was threefold higher among Caucasianassociated with an increased risk for hip fracture. Other
males and fourfold higher among Caucasian females thanfactors that were not important predictors of hip fracture
the reference population. The magnitude of the RR ofincluded treatment modality and smoking status, serum
hip fracture was lower when we did not exclude non-intact PTH (iPTH), calcium, aluminum, and bicarbonate
Caucasians. This is due to the higher incidence of hiplevels at the time the study started.
fracture among Caucasians compared with blacks andThe age-, gender-, and race-adjusted RRs for hip frac-
the higher proportion of black patients in our ESRDture are shown in Table 2. Factors that were associated
population than in our reference population.with an increased risk of hip fracture included increasing
Our data are consistent with prior studies in the gen-age, female gender, Caucasian race, PVD, lower BMI,
eral population, which have shown that demographicand current cigarette smoking. For each decade of life,
characteristics including increasing age, female gender,the RR of hip fracture rose by 51% (RR 5 1.51, 95%
Caucasian race, and lower BMI are associated with anCI 1.29 to 1.76, P , 0.001). Women were at a two-fold
increased risk of hip fracture [4, 7, 16–20]. It is wellincreased risk of hip fracture compared with men (RR 5
documented in the general population that African2.19, 95% CI 1.44 to 3.33, P , 0.001). Blacks were at
American patients have higher bone mineral density and46% lower risk of hip fracture than Caucasians (RR 5
are at decreased risk for fracture than Caucasians [11,0.54, 95% CI 0.34 to 0.84, P 5 0.007). For each unit
21–24]. There are several hypotheses to explain this ob-increase in the BMI, the risk of hip fracture decreased
servation, including a higher peak bone mass at maturity,by 10% (RR 5 0.90, 95% CI 0.86 to 0.94, P , 0.001).
a peak in bone mass later in life, and a greater averageThose with PVD were at 85% increased risk of hip frac-
body weight among blacks compared with Caucasiansture (RR 5 1.85; 95% CI 1.23 to 2.77, P 5 0.003). Current
[22, 25, 26].smokers were at 87% increased risk of hip fracture com-
We also found that a BMI of less than 23 was associ-pared with those who had never smoked (RR 5 1.87,
95% CI 1.04 to 3.35, P 5 0.03). ated with a 2.51 increased risk for hip fracture and that
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Table 2. Adjusted and unadjusted relative risk of fracture among patients with end-stage renal disease (ESRD)
Unadjusted Adjusteda
Person- Incidence Relative risk Relative risk
Covariate years Fractures rateb (95% CI) P value (95% CI)a P value
Age (per decade) 1.57(1.35,1.83) ,0.001 1.51(1.29,1.76) ,0.001
Less than 50 4869 16 3.29 Referent
51 to 65 4536 21 4.63 1.33(0.70, 2.56) 0.386 1.14(0.59, 2.20) 0.701
66 to 80 4200 46 10.95 2.98(1.68, 5.27) ,0.001 2.44(1.37, 4.34) 0.002
Greater than 80 536 20 37.31 9.30(4.80,17.99) ,0.001 7.52(3.86,14.63) ,0.001
Gender female vs. male 6766 70 10.35 2.29(1.52,3.47) ,0.001 2.19(1.44,3.33) ,0.001
Race 0.003 0.007
Caucasian 6656 66 9.92 Referent
Black 6029 27 4.48 0.47(0.30,0.74) 0.001 0.54(0.34,0.84) 0.007
Other 1229 9 7.32 0.78(0.39,1.56) 0.478 0.90(0.45,1.81) 0.769
Modality 0.471 0.956
Hemodialysis 12014 95 7.91 Referent
Peritoneal dialysis 288 1 3.47 0.45(0.06,3.19) 0.427 0.52(0.07,3.78) 0.522
Transplant 1351 4 2.96 0.54(0.20,1.49) 0.234 1.01(0.35,2.88) 0.987
BMI kg/m2 (continuous) 0.89(0.86,0.93) ,0.001 0.90(0.86, 0.94) ,0.001
23 and above 8171 36 4.41 Referent
Less than 23 5612 67 11.94 2.65(1.77,3.98) ,0.001 2.54(1.68,3.83) ,0.001
Peripheral vascular disease 2830 39 13.78 2.17(1.45,3.24) ,0.001 1.85(1.23,2.77) 0.003
Diabetes yes vs. no 4760 35 7.35 0.97(0.64,1.46) 0.873 0.89(0.59,1.36) 0.597
Smoking status 0.122 ,0.001
Former vs. never 3525 16 4.54 0.59(0.34,1.03) 0.063 0.70(0.40,1.24) 0.220
Current vs. never 2029 16 7.89 1.03(0.59,1.80) 0.911 1.87(1.04,3.35) 0.035
Coronary artery disease yes vs. no 4537 44 9.70 1.43(0.96,2.12) 0.077 0.96(0.64,1.45) 0.854
Cerebrovascular disease yes vs. no 1645 20 12.16 1.66(1.02,2.71) 0.042 1.37(0.83,2.24) 0.218
Unable to transfer independently 1203 16 13.30 1.75(1.02,2.99) 0.040 1.31(0.76,2.26) 0.325
Unable to ambulate independently 1353 18 13.30 1.84(1.10,3.06) 0.019 1.43(0.85,2.41) 0.174
PTH pg/mL (continuous; quadratic) 0.551 0.520
100 to 300 2846 18 6.32 Referent
Less than 100 4008 34 8.48 1.34(0.76,2.37) 0.319 1.17(0.66,2.08) 0.590
Greater than 300 2969 17 5.73 0.92(0.47,1.78) 0.804 1.16(0.60,2.26) 0.660
Calcium mg/dL 0.98(0.83,1.16) 0.827 0.93(0.78,1.10) 0.394
Albumin mg/dL 0.60(0.40,0.91) 0.016 0.73(0.47,1.13) 0.161
Aluminum lg/L 1.00(1.00,1.01) 0.229 1.00(1.00,1.01) 0.212
Phosphorous mg/dL 0.95(0.86,1.05) 0.308 1.02(0.92,1.13) 0.719
Bicarbonate mEq/L 1.03(0.98,1.08) 0.309 1.01(0.96,1.06) 0.676
Hematocrit % 0.98(0.94,1.03) 0.445 0.96(0.92,1.01) 0.124
a Adjusted for age, gender, race
b per 1000 patient-years
for each unit increase in BMI, the risk of hip fracture decreased annually more than one standard deviation
from the mean [29]. In addition, it is possible that subjectsdecreased by 11%. This is consistent with studies in the
general population, which have found a 4.2-fold (95% with PVD are more likely to fall because of amputations,
peripheral neuropathy, or other associated conditionsCI 1.3 to 14.0) increase risk of hip fracture among black
women with a BMI between 22.7 and 24.4 compared that may influence balance. The presence of PVD may
also be a marker for health, duration of smoking, andwith a BMI $31.6 [27]. Our data are also consistent with a
report of Caucasian men in which the risk of hip fracture functional status or immobility, which results in loss of
bone, a risk factor for fracture. This is consistent withdecreased by 12% (95% CI 3 to 20%) for each unit
increase in BMI [28]. BMI may be a marker for an underly- studies in the nondialysis population, which have demon-
strated that chronic illness and measures of disability areing illness that increases the risk of fracture. Alternatively,
a higher BMI may independently influence the character- associated with an increased risk of hip fracture [7, 30,
31]. In the unadjusted model, CVD, inability to ambulateistics of bone by increasing the mass of adipose tissue
available for estrogen production or increasing the pad- independently, and inability to transfer independently
were associated with an increased risk of hip fractureding at the hips to mitigate the forces during a fall [5].
We observed that PVD was associated with an in- but were no longer independently predictive when PVD
was added to the model. CVD and ability to ambulatecreased risk for hip fracture. Reduced blood flow to the
extremities may effect bone remodeling, resulting in a and transfer are markers of disability and have been
associated with an increased risk of falls in the generalloss of bone. Vogt et al reported a greater rate of bone
loss at the hip among patients whose ankle/arm index population [32]. However, it is possible that among
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Table 3. Relative risk of fracture in the final multivariate model and acidosis are associated with an increased risk for
bone loss and may place patients at increased risk forRelative riska
Covariate (95% CI) P value fracture [8, 10, 12, 39–41]. A cross-sectional study of
Age (10 years) 1.40(1.20,1.64) ,0.001 Japanese males on hemodialysis demonstrated that those
Less than 50 Referent with low iPTH levels had a greater risk of vertebral
51 to 65 1.20(0.61,2.34) 0.603
fractures [12]. Although we did not assess risk factors66 to 80 2.25(1.24,4.10) 0.008
Greater than 80 5.98(2.98,11.98) ,0.001 for vertebral fracture, our data did not demonstrate an
Gender female vs. male 2.26(1.48,3.44) ,0.001 association between hip fracture and duration of dialysis,
Race 0.008
iPTH, calcium, phosphate, or aluminum. Our laboratoryCaucasian Referent
Black 0.58(0.37,0.91) 0.019 data are from single measurements. Future studies
Other 0.89(0.44,1.79) 0.744 should assess the burden of dialysis associated abnormal-
Modality 0.972
ities over time to estimate the relationships more accu-Hemodialysis Referent
Peritoneal dialysis 0.56(0.08,4.07) 0.57 rately. It is possible that the higher RR of hip fracture
Transplant 1.03(0.36,2.95) 0.962 among ESRD patients is accounted for by a greater
BMI kg/m2 (continuous) 0.89(0.86,0.93) ,0.001
burden of known risk factors for hip fracture such as23 and above Referent
Less than 23 2.51(1.65,3.82) ,0.001 diabetes, hypogonadism, PVD, low bone mass, immobil-
Peripheral vascular disease 1.94(1.29,2.92) 0.002 ity, and protein wasting.
aAdjusted for all covariates listed This study has several limitations. First, the validity
of our study depends on the accuracy of the ICD-9 coding
in the USRDS hospitalization file. However, reports of
Medicare hospitalization data for hip fracture have been
ESRD patients, PVD may be a better measure of disabil-
shown to have high validity since the majority of hip
ity and fall risk.
fractures result in hospitalization [42]. Second, we were
We found that current cigarette smoking was an im- unable to assess the contribution of unmeasured risk
portant risk factor for hip fracture in dialysis patients, factors such as hypogonadism and medications such as
after adjusting for age, gender, and race [4, 33, 34]. How- steroids on the risk of hip fractures. Further studies are
ever, after also adjusting for BMI, smoking was no longer necessary to clarify the role of these factors in the risk
a significant predictor of hip fracture. This is consistent of hip fracture. Third, we had limited power to address
with data from the general population in which smoking the impact of modality on hip fracture risk. Finally, high
is thought to increase the risk of hip fracture by decreas- mortality rates in the study population may have com-
ing normal weight gain, adversely affecting general peted with hip fracture as an event. Risks that may have
health and exercise, and altering sex hormone metabo- eventually led to fracture may have first led to mortality,
lism [35]. In women, the spine and distal radius are most thus influencing our results. This problem was carefully
affected by cigarette smoking, since these sites are more considered in the analysis design, but given the data
sensitive to estrogen [36, 37]. Because we assessed frac- available, there is no way to “separate” the two events.
tures at the hip, cigarette smoking may have had less With that said, the observed fracture rate in the study
impact on bone metabolism at this site. Smoking may population remained higher than that associated with
also be less important among ESRD patients who al- the general population, leaving us confident that our goal
ready have a high incidence of hypogonadism. of identifying factors leading to an increased rate of
Although studies have shown that patients who have hip fracture in the ESRD population was attained with
undergone transplantation are at increased risk for frac- minimal bias. Although our study has several limitations,
ture compared with the general population [38], we did to our knowledge it is the first study to identify risk
not find transplantation to increase the risk of hip frac- factors associated with hip fracture in the dialysis popula-
ture compared with dialysis. It is possible that the risk tion. In addition, as a population-based study, the results
of hip fracture associated with transplantation is not sig- are not a reflection of dialysis unit specific characteristics
nificantly greater that the already high RR of fracture and therefore can be generalized to the entire ESRD
associated with dialysis. Alternatively, the number of population.
transplanted patients was relatively small, and the upper Demographic and other characteristics that predict
confidence limit of the RR (2.95) is compatible with a risk of hip fracture in the population at large also do so
true increase in risk. in ESRD patients. However, we were unable to identify
We have previously reported that ESRD patients are characteristics of ESRD or its treatment that were inde-
at a fourfold greater risk of hip fracture compared with pendently related to hip fracture incidence. Interventions
the general population [2]. Investigators have suggested that improve nutrition may be useful in reducing the risk
that factors unique to the dialysis population such as of hip fracture. Other studies will be needed to identify
risk factors that might be amenable to intervention.renal osteodystrophy, amyloid, aluminum intoxication,
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